Oct 1 (Reuters) – JCR Pharmaceuticals Co Ltd: * JCR PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH MENAGEN TO COMMERCIALIZE AGALSIDASE BETA BS I.V. INFUSION ACROSS NINE MENAT MARKETS * JCR PHARMACEUTICALS CO LTD: DOES NOT EXPECT A MATERIAL IMPACT ON FY2025 CONSOLIDATED RESULTS FROM MENAGEN DEAL Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Berlin (dpa) - Having someone you share a special emotional bond with, walk hand in…
Donville-les-Bains (dpa) – Try this delicious recipe for scallops, created by a Normandy restaurant famous…
Berlin (dpa) - The great thing about pumpkin is that it's incredibly versatile in the…
उदय राज आनंद, सीईओ – डोमेस्टिक बिजनेस, पारिजात इंडस्ट्रीज नई दिल्ली, 21 अक्टूबर: खरीफ़ सीजन के बाद, भारत का…
Los Angeles (tca/dpa) - My boyfriend turned 50 this year. He didn't buy an expensive…
Los Angeles (PA Media/dpa) - People have long been warned that eating late at night leads…